S 6422

  • New York Senate Bill
  • 2025 Regular Session
  • Introduced in Senate
  • Senate
  • Assembly
  • Governor

Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Abstract

Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.

Bill Sponsors (2)

Votes


No votes to display

Actions


Mar 13, 2025

Senate

REFERRED TO HIGHER EDUCATION

  • Referral-Committee
HIGHER EDUCATION

Bill Text

Bill Text Versions Format
S6422 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.